Lehfilcon A contact lenses
DeviceSilicone hydrogel contact lenses with investigational coating
Other names: LID020098
NCT Number: NCT04631796
The primary objective of this study is to evaluate the overall clinical performance of an investigational silicone hydrogel contact lens over 2 weeks of daily wear.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Alcon Investigative Site, Orlando, Florida, United States
Participants will attend a Screening visit, a Dispense visit (0 to 4 days later), and a follow-up visit approximately 2 weeks after the Dispense visit.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Silicone hydrogel contact lenses with investigational coating
Other names: LID020098
Solution for cleaning, disinfecting, and reconditioning silicone hydrogel contact lenses
Other names: OPTI-FREE® RepleniSH®
Time frame: Dispense; Week 2 Follow-up
Front surface wettability (i.e., assessment of the disruption of the front surface wettability of the contact lens) was assessed by the investigator for each eye individually. Front surface wettability was collected on a 5-point scale, where where Grade 0 = a smooth uniformly reflecting surface and Grade 4 = non-wettable lens surface. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial DetailsNCT07614113
Eye Diseases, Myopia
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06668246
Ametropia, Eye Diseases
Brest, France
View Trial DetailsNCT05059041
Abnormalities, Multiple, Chromosome Disorders
Columbus, Ohio, United States
View Trial Details